Breast cancer screening in younger women: evidence and decision making

Journal of Evaluation in Clinical Practice 3 (3):179-186 (1997)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

DOI

10.1046/j.1365-2753.1997.00002.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 86,377

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Optimal two‐stage breast cancer screening for countries with intermediate or low incidence of breast cancer.Shou-Jen Kuo, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Dar-Ren Chen & Li-Sheng Chen - 2010 - Journal of Evaluation in Clinical Practice 16 (6):1345-1352.
Breast cancer incidence: what do the figures mean?Ann Johnson & Jane Shekhdar - 2005 - Journal of Evaluation in Clinical Practice 11 (1):27-31.
The medical decision-making process and the family: The case of breast cancer patients and their husbands.Roy Gilbar & Ora Gilbar - 2008 - Bioethics 23 (3):183-192.
Patient, physician and presentational influences on clinical decision making for breast cancer: results from a factorial experiment.John B. McKinlay, Risa B. Burns, Richard Durante, Henry A. Feldman, Karen M. Freund, Brooke S. Harrow, Julie T. Irish, Linda E. Kasten & Mark A. Moskowitz - 1997 - Journal of Evaluation in Clinical Practice 3 (1):23-57.
Rational choice(s)? Rethinking decision-making on breast cancer risk and screening mammography.Mandana Vahabi & Denise Gastaldo - 2003 - Nursing Inquiry 10 (4):245-256.
Collective Fear, Individualized Risk: the social and cultural context of genetic testing for breast cancer.N. Press, J. R. Fishman & B. A. Koenig - 2000 - Nursing Ethics 7 (3):237-249.
Problems associated with randomized controlled clinical trials in breast cancer.Ann E. Johnson - 1998 - Journal of Evaluation in Clinical Practice 4 (2):119-126.
Riposte to Guest Commentaries on 'Problems associated with randomized controlled clinical trials in breast cancer'.Ann E. Johnson - 1998 - Journal of Evaluation in Clinical Practice 4 (3):231-236.
How would a latent period for early breast cancer affect the benefit of screening?Leslie E. Blumenson - 1987 - Theoretical Medicine and Bioethics 2 (2):169-182.
Exploring the requirements for a decision aid on familial breast cancer in the UK context: a qualitative study with patients referred to a cancer genetics service.Rachel Iredale, Frances Rapport, Stephanie Sivell, Wendy Jones, Adrian Edwards, Jonathon Gray & Glyn Elwyn - 2008 - Journal of Evaluation in Clinical Practice 14 (1):110-115.
Debating the Desirability of New Biomedical Technologies: Lessons from the Introduction of Breast Cancer Screening in the Netherlands. [REVIEW]Marianne Boenink - 2012 - Health Care Analysis 20 (1):84-102.
Evaluation of a community‐based intervention to enhance breast cancer screening practices in Brazil.Luiz Claudio Santos Thuler & Hilda Guimaraes Freitas - 2008 - Journal of Evaluation in Clinical Practice 14 (6):1012-1017.
God, disease, and spiritual dilemmas: Reading the lives of women with breast cancer.Megan Eide & Ann Milliken Pederson - 2009 - Zygon 44 (1):85-96.
Interactive patient decision aids for women facing genetic testing for familial breast cancer: a systematic web and literature review.Lisa Williams, Wendy Jones, Glyn Elwyn & Adrian Edwards - 2008 - Journal of Evaluation in Clinical Practice 14 (1):70-74.

Analytics

Added to PP
2013-11-24

Downloads
18 (#681,650)

6 months
2 (#520,889)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references